CCCC

C4 Therapeutics, Inc.

1.90

USD

CCCC Earnings Reports

Positive Surprise Ratio

CCCC beat 13 of 21 last estimates.

62%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$6.59M

-$0.30

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

+27.28%

-38.78%

C4 Therapeutics, Inc. earnings per share and revenue

On --, CCCC reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.30 USD, with revenue projected to reach 6.59 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

FAQ

What were C4 Therapeutics, Inc.'s earnings and revenue for the latest quarter Q-- --?

For Q-- --, C4 Therapeutics, Inc. reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to C4 Therapeutics, Inc.'s Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is C4 Therapeutics, Inc. expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for C4 Therapeutics, Inc.'s next earnings report?

Based on 9 analysts, C4 Therapeutics, Inc. is expected to report EPS of -$0.30 and revenue of $6.59M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.